# Phase 4 thromboembolism trials recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 4 for thromboembolism that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 thromboembolism trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/thromboembolism

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 30, 2026 | NCT07907211 | Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma | Sponsor not shown (see the record) | Phase 4 | Recruiting | Multiple Myeloma, Venous Thromboembolism (VTE) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907211) |
| October 1, 2026 | NCT07852637 | Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism | Samsung Medical Center | Phase 4 | Not yet recruiting | Venous Thromboembolism, Active Cancer | 2,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852637) |
| September 25, 2026 | NCT07840352 | Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications | Teleflex | Phase 4 | Not yet recruiting | Thromboembolic Event, FDP | 867 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840352) |
| July 20, 2026 | NCT07713875 | Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Spine Metastasis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713875) |
| March 13, 2026 | NCT07469488 | A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced... | Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor... | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469488) |
| December 26, 2025 | NCT07303816 | Statins to Prevent Cancer Associated Blood Clots | Brigham and Women's Hospital | Phase 4 | Recruiting | Venous Thromboembolism, Cancer, Cardiovascular Events | 4,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303816) |
| November 21, 2025 | NCT07243080 | Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention | Mayo Hospital Lahore | Phase 4 | Recruiting | Deep Venous Thromboses, Laparotomy Patients | 212 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243080) |
| September 24, 2025 | NCT07189897 | Apixaban or Enoxaparin After Head and Neck Cancer Surgery | Sponsor not shown (see the record) | Phase 4 | Recruiting | Venous Thromboembolism, Head and Neck Cancer | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189897) |
| July 23, 2025 | NCT07081035 | Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3... | Asan Medical Center | Phase 4 | Not yet recruiting | Advanced Heart Failure, Left Ventricular Assist Devices, Anticoagulation Treatment, Bleeding Complications, Thrombotic... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07081035) |
| May 6, 2025 | NCT06958588 | Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis | Science Valley Research Institute | Phase 4 | Recruiting | Venous Thromboembolism (VTE), Intensive Care Medicine, Venous Thromboembolism | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06958588) |
| March 12, 2025 | NCT06873321 | VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization | Science Valley Research Institute | Phase 4 | Recruiting | Peripheral Arterial Disease, Venous Thormboembolism, Cardiovascular Diseases, Vascular Surgery Patient with PAD /... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06873321) |
| February 25, 2025 | NCT06845423 | Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk | University Hospital, Brest | Phase 4 | Recruiting | Venous Thromboembolism (VTE), Post Partum Women | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06845423) |
| December 31, 2024 | NCT06754371 | Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage | RenJi Hospital | Phase 4 | Recruiting | Postpartum Hemorrhage, Systemic Autoimmune Diseases | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06754371) |
| September 19, 2024 | NCT06603870 | Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis | Ottawa Hospital Research Institute | Phase 4 | Recruiting | Venous Thromboembolism, Cancer, Upper Extremity Deep Vein Thrombosis, Catheter-Related Infections | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06603870) |
| September 3, 2024 | NCT06581965 | inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee... | Leiden University Medical Center | Phase 4 | Recruiting | Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis | 10,078 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06581965) |
| July 29, 2024 | NCT06523959 | Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial | Clinical Urology and Epidemiology Working Group | Phase 4 | Recruiting | Venous Thromboembolism, Bleeding | 5,436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06523959) |
| June 4, 2024 | NCT06442267 | Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support | Medical University of Vienna | Phase 4 | Recruiting | Respiratory Insufficiency, Circulatory Failure, Thromboembolism, Bleeding | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06442267) |
| February 21, 2023 | NCT05735639 | THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) | Imperial College London | Phase 4 | Recruiting | Venous Thromboembolism, Varicose Veins | 3,175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05735639) |
| February 10, 2020 | NCT04263038 | Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism | Sponsor not shown (see the record) | Phase 4 | Recruiting | Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, Respiratory Tract... | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04263038) |
| February 6, 2020 | NCT04258488 | Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement | Sponsor not shown (see the record) | Phase 4 | Recruiting | AORTIC VALVE DISEASES, Thromboembolism | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04258488) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Science Valley Research Institute | 2 |
| Asan Medical Center | 1 |
| Ottawa Hospital Research Institute | 1 |
| Medical University of Vienna | 1 |
| Clinical Urology and Epidemiology Working Group | 1 |
| Shanghai Pulmonary Hospital, Shanghai, China | 1 |
| Samsung Medical Center | 1 |
| Leiden University Medical Center | 1 |
| University Hospital, Brest | 1 |
| RenJi Hospital | 1 |
| Imperial College London | 1 |
| Mayo Hospital Lahore | 1 |
| Teleflex | 1 |
| Brigham and Women's Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| South Korea | 3 |
| China | 3 |
| United States | 3 |
| Canada | 2 |
| France | 2 |
| Netherlands | 2 |
| Brazil | 2 |
| Belgium | 1 |
| Switzerland | 1 |
| Austria | 1 |
| Finland | 1 |
| United Kingdom | 1 |
| Pakistan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Machinery and tool manufacturers in the United States](https://specstream.ai/data/businesses/machinery-and-tool-manufacturers/united-states)
- [Portuguese restaurants in the United States](https://specstream.ai/data/businesses/portuguese-restaurants/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Architectural design firms in the United States](https://specstream.ai/data/businesses/architectural-design-firms/united-states)
- [Certification bodies in the United States](https://specstream.ai/data/businesses/certification-bodies/united-states)
- [Escrow companies in the United States](https://specstream.ai/data/businesses/escrow-companies/united-states)
